Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sublingual Y-2(Edaravone And Borneol) Tablet For Acute Ischemic And Hemorrhagic Patients-the SALVAGE Trial

NCT03495206 is registered in ClinicalTrials.gov with Yantai YenePharma Co., Ltd. as lead sponsor.

NCT NCT03495206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03495206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sublingual Y-2(Edaravone And Borneol) Tablet For Acute Ischemic And Hemorrhagic Patients-the SALVAGE Trial
Lead sponsor
Yantai YenePharma Co., Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
October 25, 2018
Completion date
February 28, 2021
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial hemorrhages, stroke, acute